Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Agrin-LRP4-MuSK signaling as a therapeutic target for myasthenia gravis and other neuromuscular disorders.

Ohno K, Ohkawara B, Ito M.

Expert Opin Ther Targets. 2017 Oct;21(10):949-958. doi: 10.1080/14728222.2017.1369960. Epub 2017 Aug 24. Review.

PMID:
28825343
2.

Pretreatment and prophylaxis against nerve agent poisoning: Are undesirable behavioral side effects unavoidable?

Myhrer T, Aas P.

Neurosci Biobehav Rev. 2016 Dec;71:657-670. doi: 10.1016/j.neubiorev.2016.10.017. Epub 2016 Oct 20. Review.

PMID:
27773692
3.

SAR study to find optimal cholinesterase reactivator against organophosphorous nerve agents and pesticides.

Gorecki L, Korabecny J, Musilek K, Malinak D, Nepovimova E, Dolezal R, Jun D, Soukup O, Kuca K.

Arch Toxicol. 2016 Dec;90(12):2831-2859. Epub 2016 Aug 31. Review.

PMID:
27582056
4.

Neurosteroids for the potential protection of humans against organophosphate toxicity.

Reddy DS.

Ann N Y Acad Sci. 2016 Aug;1378(1):25-32. doi: 10.1111/nyas.13160. Epub 2016 Jul 23. Review.

5.

α-Linolenic Acid, A Nutraceutical with Pleiotropic Properties That Targets Endogenous Neuroprotective Pathways to Protect against Organophosphate Nerve Agent-Induced Neuropathology.

Piermartiri T, Pan H, Figueiredo TH, Marini AM.

Molecules. 2015 Nov 12;20(11):20355-80. doi: 10.3390/molecules201119698. Review.

6.

The potential of sec-butylpropylacetamide (SPD) and valnoctamide and their individual stereoisomers in status epilepticus.

Shekh-Ahmad T, Mawasi H, McDonough JH, Yagen B, Bialer M.

Epilepsy Behav. 2015 Aug;49:298-302. doi: 10.1016/j.yebeh.2015.04.012. Epub 2015 May 13. Review.

PMID:
25979572
7.

Developments in alternative treatments for organophosphate poisoning.

Iyer R, Iken B, Leon A.

Toxicol Lett. 2015 Mar 4;233(2):200-6. doi: 10.1016/j.toxlet.2015.01.007. Epub 2015 Jan 13. Review.

PMID:
25595305
8.

Choice of approaches in developing novel medical countermeasures for nerve agent poisoning.

Myhrer T, Aas P.

Neurotoxicology. 2014 Sep;44:27-38. doi: 10.1016/j.neuro.2014.04.011. Epub 2014 May 9. Review.

PMID:
24820435
9.

Being prepared: emergency treatment following a nerve agent release.

Bailey AM, Baker SN, Baum RA, Chandler HE, Weant KA.

Adv Emerg Nurs J. 2014 Jan-Mar;36(1):22-33; quiz 34-5. doi: 10.1097/TME.0000000000000008. Review.

PMID:
24487260
10.

Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection.

Singh M, Kaur M, Kukreja H, Chugh R, Silakari O, Singh D.

Eur J Med Chem. 2013;70:165-88. doi: 10.1016/j.ejmech.2013.09.050. Epub 2013 Oct 6. Review.

PMID:
24148993
11.

Penehyclidine hydrochloride: a potential drug for treating COPD by attenuating Toll-like receptors.

Xiao HT, Liao Z, Tong RS.

Drug Des Devel Ther. 2012;6:317-22. doi: 10.2147/DDDT.S36555. Epub 2012 Nov 1. Review.

12.

Ketamine combinations for the field treatment of soman-induced self-sustaining status epilepticus. Review of current data and perspectives.

Dorandeu F, Barbier L, Dhote F, Testylier G, Carpentier P.

Chem Biol Interact. 2013 Mar 25;203(1):154-9. doi: 10.1016/j.cbi.2012.09.013. Epub 2012 Oct 5. Review.

PMID:
23044489
14.

Exposure to nerve agents: from status epilepticus to neuroinflammation, brain damage, neurogenesis and epilepsy.

de Araujo Furtado M, Rossetti F, Chanda S, Yourick D.

Neurotoxicology. 2012 Dec;33(6):1476-90. doi: 10.1016/j.neuro.2012.09.001. Epub 2012 Sep 7. Review.

PMID:
23000013
15.

Acetylcholinesterase inhibitors: a patent review (2008 - present).

Pohanka M.

Expert Opin Ther Pat. 2012 Aug;22(8):871-86. doi: 10.1517/13543776.2012.701620. Epub 2012 Jul 6. Review.

PMID:
22768972
16.

Analytical approaches for monitoring exposure to organophosphorus and carbamate agents through analysis of protein adducts.

Schopfer LM, Lockridge O.

Drug Test Anal. 2012 Mar-Apr;4(3-4):246-61. doi: 10.1002/dta.1325. Epub 2012 Feb 22. Review.

PMID:
22359362
17.

Crossroads in the evaluation of paraoxonase 1 for protection against nerve agent and organophosphate toxicity.

Valiyaveettil M, Alamneh YA, Doctor BP, Nambiar MP.

Toxicol Lett. 2012 Apr 5;210(1):87-94. doi: 10.1016/j.toxlet.2012.01.013. Epub 2012 Jan 25. Review.

PMID:
22301377
18.

Cholinesterases, a target of pharmacology and toxicology.

Pohanka M.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Sep;155(3):219-29. doi: 10.5507/bp.2011.036. Review.

19.

Emergency management of chemical weapons injuries.

Anderson PD.

J Pharm Pract. 2012 Feb;25(1):61-8. doi: 10.1177/0897190011420677. Epub 2011 Nov 11. Review.

PMID:
22080590
20.

Nitric oxide, epileptic seizures, and action of antiepileptic drugs.

Banach M, Piskorska B, Czuczwar SJ, Borowicz KK.

CNS Neurol Disord Drug Targets. 2011 Nov;10(7):808-19. Review.

PMID:
21999730

Supplemental Content

Loading ...
Support Center